# United States Lime & Minerals Inc: financial statements, quarterly

USLM · Nasdaq · CIK 82020 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/uslm.md) · [Financials](/companies/uslm/financials.md) · [Filings](/companies/uslm/filings.md) · [Insiders](/companies/uslm/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/uslm/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [74.9](/filings/0001558370-24-014049.md) | [65.7 d](/filings/0001104659-26-020480.md) | [71.7](/filings/0001558370-25-006101.md) | [76.5](/filings/0001558370-25-009897.md) | [89.4](/filings/0001104659-25-104345.md) | [80.1 d](/filings/0001104659-26-020480.md) | [91.3](/filings/0001104659-26-052866.md) | [91.5](/filings/0001104659-26-088668.md) | [102](/filings/0001104659-25-104345.md) | [87.9 d](/filings/0001104659-26-020480.md) | [87.8](/filings/0001104659-26-052866.md) | [99.1](/filings/0001104659-26-088668.md) |
| Cost of revenue | $m | [46.7](/filings/0001558370-24-014049.md) | [42.1 d](/filings/0001104659-26-020480.md) | [41.1](/filings/0001558370-25-006101.md) | [41.7](/filings/0001558370-25-009897.md) | [46.3](/filings/0001104659-25-104345.md) | [44.6 d](/filings/0001104659-26-020480.md) | [45.1](/filings/0001104659-26-052866.md) | [49.6](/filings/0001104659-26-088668.md) | [49.8](/filings/0001104659-25-104345.md) | [45.8 d](/filings/0001104659-26-020480.md) | [46.1](/filings/0001104659-26-052866.md) | [52.4](/filings/0001104659-26-088668.md) |
| Gross profit | $m | [28.2](/filings/0001558370-24-014049.md) | [23.6 d](/filings/0001104659-26-020480.md) | [30.6](/filings/0001558370-25-006101.md) | [34.8](/filings/0001558370-25-009897.md) | [43.1](/filings/0001104659-25-104345.md) | [35.4 d](/filings/0001104659-26-020480.md) | [46.2](/filings/0001104659-26-052866.md) | [41.9](/filings/0001104659-26-088668.md) | [52.2](/filings/0001104659-25-104345.md) | [42.2 d](/filings/0001104659-26-020480.md) | [41.8](/filings/0001104659-26-052866.md) | [46.7](/filings/0001104659-26-088668.md) |
| Selling, general and administrative | $m | [4.4](/filings/0001558370-24-014049.md) | [4.6 d](/filings/0001104659-26-020480.md) | [4.8](/filings/0001558370-25-006101.md) | [4.9](/filings/0001558370-25-009897.md) | [5.0](/filings/0001104659-25-104345.md) | [4.4 d](/filings/0001104659-26-020480.md) | [6.3](/filings/0001104659-26-052866.md) | [6.2](/filings/0001104659-26-088668.md) | [5.9](/filings/0001104659-25-104345.md) | [6.2 d](/filings/0001104659-26-020480.md) | [6.0](/filings/0001104659-26-052866.md) | [6.1](/filings/0001104659-26-088668.md) |
| Operating income | $m | [23.8](/filings/0001558370-24-014049.md) | [19.0 d](/filings/0001104659-26-020480.md) | [25.8](/filings/0001558370-25-006101.md) | [29.9](/filings/0001558370-25-009897.md) | [38.1](/filings/0001104659-25-104345.md) | [31.1 d](/filings/0001104659-26-020480.md) | [39.9](/filings/0001104659-26-052866.md) | [35.7](/filings/0001104659-26-088668.md) | [46.3](/filings/0001104659-25-104345.md) | [36.0 d](/filings/0001104659-26-020480.md) | [35.8](/filings/0001104659-26-052866.md) | [40.7](/filings/0001104659-26-088668.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [5.3](/filings/0001558370-24-014049.md) | [4.4 d](/filings/0001104659-26-020480.md) | [5.9](/filings/0001558370-25-006101.md) | [6.7](/filings/0001558370-25-009897.md) | [7.8](/filings/0001104659-25-104345.md) | [7.2 d](/filings/0001104659-26-020480.md) | [8.9](/filings/0001104659-26-052866.md) | [8.0](/filings/0001104659-26-088668.md) | [10.9](/filings/0001104659-25-104345.md) | [9.0 d](/filings/0001104659-26-020480.md) | [8.4](/filings/0001104659-26-052866.md) | [9.5](/filings/0001104659-26-088668.md) |
| Net income | $m | [20.7](/filings/0001558370-24-014049.md) | [17.0 d](/filings/0001104659-26-020480.md) | [22.4](/filings/0001104659-25-104345.md) | [26.1](/filings/0001104659-25-104345.md) | [33.4](/filings/0001104659-25-104345.md) | [27.0 d](/filings/0001104659-26-020480.md) | [34.1](/filings/0001104659-26-088668.md) | [30.8](/filings/0001104659-26-088668.md) | [38.8](/filings/0001104659-25-104345.md) | [30.5 d](/filings/0001104659-26-020480.md) | [30.6](/filings/0001104659-26-088668.md) | [34.5](/filings/0001104659-26-088668.md) |
| Diluted EPS | $ per share | [0.73](/filings/0001558370-24-014049.md) | not reported | [0.78](/filings/0001558370-25-006101.md) | [0.91](/filings/0001558370-25-009897.md) | [1.16](/filings/0001104659-25-104345.md) | not reported | [1.19](/filings/0001104659-26-052866.md) | [1.07](/filings/0001104659-26-088668.md) | [1.35](/filings/0001104659-25-104345.md) | not reported | [1.06](/filings/0001104659-26-052866.md) | [1.20](/filings/0001104659-26-088668.md) |
| Basic EPS | $ per share | [0.73](/filings/0001558370-24-014049.md) | not reported | [0.79](/filings/0001558370-25-006101.md) | [0.91](/filings/0001558370-25-009897.md) | [1.17](/filings/0001104659-25-104345.md) | not reported | [1.19](/filings/0001104659-26-052866.md) | [1.08](/filings/0001104659-26-088668.md) | [1.35](/filings/0001104659-25-104345.md) | not reported | [1.07](/filings/0001104659-26-052866.md) | [1.20](/filings/0001104659-26-088668.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [176](/filings/0001558370-23-017442.md) | [188](/filings/0001558370-25-001798.md) | [207](/filings/0001558370-24-006378.md) | [223](/filings/0001558370-24-010716.md) | [255](/filings/0001558370-24-014049.md) | [278](/filings/0001104659-26-020480.md) | [301](/filings/0001558370-25-006101.md) | [320](/filings/0001558370-25-009897.md) | [350](/filings/0001104659-25-104345.md) | [371](/filings/0001104659-26-088668.md) | [383](/filings/0001104659-26-052866.md) | [403](/filings/0001104659-26-088668.md) |
| Current assets | $m | [246](/filings/0001558370-23-017442.md) | [255](/filings/0001558370-25-001798.md) | [279](/filings/0001558370-24-006378.md) | [300](/filings/0001558370-24-010716.md) | [338](/filings/0001558370-24-014049.md) | [355](/filings/0001104659-26-020480.md) | [388](/filings/0001558370-25-006101.md) | [403](/filings/0001558370-25-009897.md) | [440](/filings/0001104659-25-104345.md) | [455](/filings/0001104659-26-088668.md) | [476](/filings/0001104659-26-052866.md) | [500](/filings/0001104659-26-088668.md) |
| Total assets | $m | [424](/filings/0001558370-24-014049.md) | [441](/filings/0001558370-25-001798.md) | [464](/filings/0001558370-24-006378.md) | [484](/filings/0001558370-24-010716.md) | [522](/filings/0001558370-24-014049.md) | [543](/filings/0001104659-26-020480.md) | [585](/filings/0001558370-25-006101.md) | [607](/filings/0001558370-25-009897.md) | [653](/filings/0001104659-25-104345.md) | [681](/filings/0001104659-26-088668.md) | [714](/filings/0001104659-26-052866.md) | [747](/filings/0001104659-26-088668.md) |
| Current liabilities | $m | [16.0](/filings/0001558370-23-017442.md) | [17.5](/filings/0001558370-25-001798.md) | [19.2](/filings/0001558370-24-006378.md) | [14.1](/filings/0001558370-24-010716.md) | [18.7](/filings/0001558370-24-014049.md) | [17.0](/filings/0001104659-26-020480.md) | [25.4](/filings/0001558370-25-006101.md) | [18.5](/filings/0001558370-25-009897.md) | [23.1](/filings/0001104659-25-104345.md) | [23.6](/filings/0001104659-26-088668.md) | [23.0](/filings/0001104659-26-052866.md) | [18.2](/filings/0001104659-26-088668.md) |
| Total liabilities | $m | [46.4](/filings/0001558370-23-017442.md) | [47.5](/filings/0001558370-25-001798.md) | [48.7](/filings/0001558370-24-006378.md) | [43.1](/filings/0001558370-24-010716.md) | [47.5](/filings/0001558370-24-014049.md) | [45.4](/filings/0001104659-26-020480.md) | [53.0](/filings/0001558370-25-006101.md) | [44.1](/filings/0001558370-25-009897.md) | [50.5](/filings/0001104659-25-104345.md) | [50.3](/filings/0001104659-26-088668.md) | [52.7](/filings/0001104659-26-052866.md) | [51.6](/filings/0001104659-26-088668.md) |
| Long-term debt | $m | [0.0](/filings/0001558370-23-017442.md) | [0.0](/filings/0001558370-25-001798.md) | [0.0](/filings/0001558370-24-006378.md) | [0.0](/filings/0001558370-24-010716.md) | [0.0](/filings/0001558370-24-014049.md) | [0.0](/filings/0001104659-26-020480.md) | [0.0](/filings/0001558370-25-006101.md) | [0.0](/filings/0001558370-25-009897.md) | [0.0](/filings/0001104659-25-104345.md) | [0.0](/filings/0001104659-26-020480.md) | [0.0](/filings/0001104659-26-052866.md) | [0.0](/filings/0001104659-26-088668.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [378](/filings/0001558370-24-014049.md) | [393](/filings/0001104659-26-020480.md) | [415](/filings/0001104659-25-104345.md) | [441](/filings/0001104659-25-104345.md) | [474](/filings/0001104659-25-104345.md) | [498](/filings/0001104659-26-088668.md) | [532](/filings/0001104659-26-088668.md) | [563](/filings/0001104659-26-088668.md) | [602](/filings/0001104659-25-104345.md) | [631](/filings/0001104659-26-088668.md) | [661](/filings/0001104659-26-088668.md) | [696](/filings/0001104659-26-088668.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [24.4 d](/filings/0001558370-24-014049.md) | [27.6 d](/filings/0001104659-26-020480.md) | [27.2](/filings/0001558370-25-006101.md) | [21.2 d](/filings/0001558370-25-009897.md) | [39.1 d](/filings/0001104659-25-104345.md) | [38.6 d](/filings/0001104659-26-020480.md) | [39.4](/filings/0001104659-26-052866.md) | [34.0 d](/filings/0001104659-26-088668.md) | [45.9 d](/filings/0001104659-25-104345.md) | [45.6 d](/filings/0001104659-26-020480.md) | [32.1](/filings/0001104659-26-052866.md) | [39.1 d](/filings/0001104659-26-088668.md) |
| Capital expenditure | $m | [5.1 d](/filings/0001558370-24-014049.md) | [13.7 d](/filings/0001104659-26-020480.md) | [6.8](/filings/0001558370-25-006101.md) | [4.4 d](/filings/0001558370-25-009897.md) | [5.2 d](/filings/0001104659-25-104345.md) | [11.0 d](/filings/0001104659-26-020480.md) | [14.9](/filings/0001104659-26-052866.md) | [13.3 d](/filings/0001104659-26-088668.md) | [14.7 d](/filings/0001104659-25-104345.md) | [19.9 d](/filings/0001104659-26-020480.md) | [18.3](/filings/0001104659-26-052866.md) | [17.9 d](/filings/0001104659-26-088668.md) |
| Dividends paid | $m | [1.1 d](/filings/0001558370-24-014049.md) | [1.1 d](/filings/0001104659-26-020480.md) | [1.4](/filings/0001558370-25-006101.md) | [1.4 d](/filings/0001558370-25-009897.md) | [1.4 d](/filings/0001104659-25-104345.md) | [1.4 d](/filings/0001104659-26-020480.md) | [1.7](/filings/0001104659-26-052866.md) | [1.7 d](/filings/0001104659-26-088668.md) | [1.7 d](/filings/0001104659-25-104345.md) | [1.7 d](/filings/0001104659-26-020480.md) | [1.7](/filings/0001104659-26-052866.md) | [1.7 d](/filings/0001104659-26-088668.md) |
| Share repurchases | $m | [0.0 d](/filings/0001558370-24-014049.md) | [1.2 d](/filings/0001104659-26-020480.md) | [0.2](/filings/0001558370-25-006101.md) | [0.0 d](/filings/0001558370-25-009897.md) | [0.0 d](/filings/0001104659-25-104345.md) | [3.3 d](/filings/0001104659-26-020480.md) | [0.4](/filings/0001104659-26-052866.md) | [0.0 d](/filings/0001104659-26-088668.md) | [0.0 d](/filings/0001104659-25-104345.md) | [2.3 d](/filings/0001104659-26-020480.md) | [0.4](/filings/0001104659-26-052866.md) | [0.0 d](/filings/0001104659-26-088668.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [5.7](/filings/0001558370-23-017442.md) | [5.7](/filings/0001558370-24-006378.md) | [28.5](/filings/0001558370-24-010716.md) | [28.6](/filings/0001558370-24-014049.md) | [28.6](/filings/0001558370-25-006101.md) | [28.7](/filings/0001558370-25-009897.md) | [28.7](/filings/0001104659-25-104345.md) | [28.7](/filings/0001104659-26-052866.md) | [28.7](/filings/0001104659-26-088668.md) | [28.7](/filings/0001104659-25-104345.md) | [28.8](/filings/0001104659-26-052866.md) | [28.8](/filings/0001104659-26-088668.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 28,688,363 at 2026-07-28, from the cover of the [10-Q filed 2026-07-30](/filings/0001104659-26-088668.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:20 ET. No prices; not investment advice.